Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Ruiz Iturriaga (Barakaldo, Spain), L. Serrano Fernandez (Barakaldo, Spain), L. Martinez-Indart (Barakaldo, Spain), A. Gomez Bonilla (Barakaldo, Spain), B. Gonzalez Quero (Barakaldo, Spain), A. Artaraz Ereño (Barakaldo, Spain), B. Ortiz De Urbina Antia (Barakaldo, Spain), P. España Yandiola (Barakaldo, Spain), R. Zalacain Jorge (Barakaldo, Spain). LONG –TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL AND LEGIONELLA PNEUMONIA. 4542

Member's Comments

No comment yet.

Related content which might interest you: LYMPHOPENIA AS PREDICTOR OF LONG TERM MORTALITY IN PATIENTS WITH HOSPITAL ACQUIRED PNEUMONIA Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 PREDICTING THE MORTALITY OF PNEUMONIA PATIENTS VISITING THE EMERGENCY DEMARTMENT THROUGH MACHINE LEARNING Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 EXCESS MORTALITY IN PATIENTS WITH ASTHMA ON LONG-ACTING β2-AGONISTS Source: Eur Respir J 2007; 29: 823 Year: 2007 PLEURAL EFFUSION IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 UTILITY OF BRONCHOALVEOLAR LAVAGE(BAL) TO DETECT INFECTIOUS COMPLICATIONS IN PATIENTS WITH SEVERE SARS-COV-2 PNEUMONIA Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 RESPIRATORY AND SLEEP DISORDERS IN 44 SPANISH PATIENTS WITH MYOTONIC DYSTROPHY TYPE I Source: International Congress 2017 – Noninvasive ventilation for chronic respiratory failure Year: 2017 A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS AND NORMAL OR BORDERLINE PULMONARY PRESSURES Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 DIAGNOSTICS, THERAPY, COURSE AND RESULTS IN PATIENTS WITH CHRONIC EXTRINSIC ALLERGIC ALVEOLITIS. Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 CELL DEATH MODES OF WHITE BLOOD CELLS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA AND PULMONARY TUBERCULOSIS Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 SURFACTANT THERAPY IN PATIENTS WITH SEVERE UNCONTROLLED BRONCHIAL ASTHMA Source: International Congress 2018 – New modalities in asthma treatment Year: 2018 PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY. Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 EFFICACY OF IRON REPLETION WITHOUT ERYTHROPOIESIS-STIMULATING AGENT IN PATIENTS WITHCHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 EVALUATION OF RESPIRATORY IMPEDANCE AND VENTILATORY HOMOGENEITY IN PATIENTS WITH PRETERM BIRTH Source: International Congress 2018 – Paediatric bronchology Year: 2018 PREVALENCE AND CHARACTERISTICS OF SAHS PATIENTS ADMITTED FOR COVID-19 PNEUMONIA Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021